| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT05819866 | A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male… | Cerebral Adrenoleukodystrophy (cALD) | Active, Not Recruiting | 2026-07-29 |
| Not specified | ||||
| NCT06178120 | Disease Progression in Women With X-linked Adrenoleukodystrophy | X-linked Adrenoleukodystrophy | Recruiting | 2024-01-31 |